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Abstract
Recent research suggests an important role of FKBP5, a glucocorticoid receptor regulating
co-chaperone, in the development of stress-related diseases such as depression and anxiety
disorders. The present study aimed to replicate and extend previous evidence indicating that
FKBP5 polymorphisms moderate hypothalamus–pituitary–adrenal (HPA) function by examining
whether FKBP5 rs1360780 genotype and different measures of childhood adversity interact to
predict stress-induced cortisol secretion. At age 19 years, 195 young adults (90 males, 105
females) participating in an epidemiological cohort study completed the Trier Social Stress Test
(TSST) to assess cortisol stress responsiveness and were genotyped for the FKBP5 rs1360780.
Childhood adversity was assessed using the Childhood Trauma Questionnaire (CTQ) and by a
standardized parent interview yielding an index of family adversity. A signiﬁcant interaction
between genotype and childhood adversity on cortisol response to stress was demonstrated for
exposure to childhood maltreatment as assessed by retrospective self-report (CTQ), but not for
prospectively ascertained objective family adversity. Severity of childhood maltreatment was
signiﬁcantly associated with attenuated cortisol levels among carriers of the rs1360780 CC
genotype, while no such effect emerged in carriers of the T allele. These ﬁndings point towards
the functional involvement of FKBP5 in long-term alterations of neuroendocrine stress
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regulation related to childhood maltreatment, which have been suggested to represent a
premorbid risk or resilience factor in the context of stress-related disorders.
& 2013 Elsevier B.V. and ECNP. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Stress-related psychiatric diseases such as mood and anxiety
disorders are the most common mental health disorders in
Western countries, with estimated 12-month prevalence rates
of up to 14% in Europe (Wittchen et al., 2011). The identiﬁca-
tion of factors underlying individual differences in stress
reactivity promises to improve the understanding and treat-
ment of such disorders. One important neurobiological system
activated by stress is the hypothalamus–pituitary–adrenal
system (HPA axis). The magnitude and duration of the
endocrine stress response are, in part, regulated by the
negative feedback of cortisol on the HPA axis activity. Cortisol
binds to glucocorticoid receptors (GR) at the level of the
hypothalamus and the pituitary, resulting in an inhibition of
ongoing CRH and ACTH release. Disturbances of the HPA axis
have been repeatedly implicated as markers of several
diseases, such as depression or Posttraumatic Stress Disorder
(PTSD). Moreover, individual variation in neuroendocrine stress
regulation has been suggested to represent a premorbid risk or
resilience factor in the context of stress-related disorders
(Binder and Holsboer, 2012).
There is ample evidence of genetic variation affecting
GR-mediated regulation of the HPA axis. Different GR gene
variants have been identiﬁed as affecting the cortisol
reactivity (Wüst et al., 2004; Derijk and de Kloet, 2008).
Growing evidence emphasizes polymorphisms of the gene
coding for FK506-binding protein 51 (FKBP5), a regulator of
GR function, as important determinants of HPA axis func-
tioning (Velders et al., 2011; Ising et al., 2008). The most
frequently investigated single nucleotide polymorphism
(SNP) of the FKBP5 gene is rs1360780, for which a functional
effect towards increased FKBP5 protein levels was ﬁrst
suggested by Binder et al. (2004). In lymphocytes of carriers
of the TT genotype, FKBP5 levels were observed to be twice
as high as in C-allele carriers. As FKBP5 is a co-chaperone
reducing the binding afﬁnity of the GR (Denny et al., 2000),
its overexpression would be expected to result in attenua-
tion of the negative feedback inhibition. Accordingly, Ising
et al. (2008) reported impaired cortisol recovery after stress
among carriers of the minor T allele. Likewise, Luijk et al.
(2010) observed increased cortisol reactivity during a stress-
ful separation procedure in 14-month-old infants carrying
the T allele.
Consistent with the assumption that neurobiological con-
sequences of elevated cortisol exposure in brain areas related
to emotional processing may contribute to the development of
mood disorders (Cowen, 2010), rs1360780 has also been linked
to major depression risk and antidepressant treatment
response (Zimmermann et al., 2011; Binder et al., 2004).
Notably, a moderating role of this polymorphism in the
vulnerability to stress-related disorders in the presence of
environmental adversity was documented. When exposed to
adverse, especially traumatic events, homozygous carriers of
the minor T allele were found to be at increased risk of
depression compared to other genotype groups (Zimmermann
et al., 2011; Appel et al., 2011). The same genotype has also
been reported to predict the severity of posttraumatic stress
symptoms after exposure to childhood adversity, suggesting
that FKBP5-mediated alteration of GR sensitivity may serve as
a potential risk factor for PTSD in the face of traumatic stress
(Binder et al., 2008; Xie et al., 2010). Further support that
genetic variation in FKBP5 may account for an increased
vulnerability to psychopathology has been provided by pre-
clinical research. When comparing wild-type mice with FKBP5
knockout animals, O'Leary et al. (2011) reported that the
deletion was associated with less corticosterone production
after stress and an increased resilience to depression-like
behavior.
Most recently, Klengel et al. (2013) suggested that epige-
netic modiﬁcations constitute a molecular mechanism which
may account for dysregulation of the stress hormone system
and increased vulnerability to stress-related disorders in
rs1360780 T-allele carriers. Genotype-dependent differences
in DNA methylation in functional glucocorticoid response
elements (GRE) of FKBP5 were linked to GR resistance and
were hypothesized to induce long-term dysregulation of the
endocrine stress system among individuals who had been
exposed to childhood trauma.
Using data from a prospective study starting at birth, we
aimed to (i) replicate the ﬁnding from previous studies
suggesting a functional involvement of the FKBP5 rs1360780
polymorphism in regulating the HPA axis response to stress
and (ii) examine whether the recently reported long-term
epigenetic changes resulting from the interaction of FKBP5
genotype with adverse childhood experiences are reﬂected
in the individuals' cortisol response to acute stress as
supposed by Klengel et al. (2013). Moreover, the present
study contributes to and extends the existing literature by
providing measures of childhood adversity drawn from both
retrospective self-report and prospectively ascertained
objective information collected in the same sample.
2. Experimental procedures
2.1. Sample
This investigation was conducted in the framework of the Mannheim
Study of Children at Risk, an ongoing epidemiological cohort study
of the long-term outcome of early risk factors (Laucht et al., 1997;
Laucht et al., 2000). Assessments were conducted at the age of
3 months and at regular intervals throughout development until
young adulthood. The present analysis comprises 195 young adults
(90 males, 105 females) who participated in the 19-year assess-
ment, including a laboratory session with a standardized psychoso-
cial stress protocol, the Trier Social Stress Test (TSST, Kirschbaum
et al., 1993), for whom all relevant information was available.
Exclusion criteria included pregnancy, potentially adverse effects in
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participants suffering from acute psychiatric symptoms, alcohol/
drug dependence or abuse, positive urine drug screening, missing or
pathological hormone data, treatment with glucocorticoids and
nausea during vein puncture. The study was approved by the ethics
committee of the University of Heidelberg and written informed
consent was obtained from all participants.
2.2. Psychological assessments
The Structured Clinical Interview for DSM-IV (SCID-I German version
(Wittchen et al., 1997)) was conducted at the age of 19 years to
assess psychiatric disorders in the young adults. To examine current
drug use, a substance use inventory was administered (Müller and
Abbet, 1991). On the day of the experiment, participants were
asked about any use of current medication. In addition, female
participants reported their menstrual cycle phase and any use of
contraceptive medications.
Childhood adversity was assessed in two ways. On the one hand,
childhood maltreatment was retrospectively assessed with the brief
screening version of the Childhood Trauma Questionnaire (CTQ,
Bernstein et al., 2003) at the age of 23 years. The CTQ is a self-
report inventory distinguishing ﬁve types of childhood maltreat-
ment, i.e. sexual, physical, and emotional abuse, and emotional
and physical neglect. Good psychometric properties have been
conﬁrmed for the German version (Wingenfeld et al., 2010). The
CTQ yields a total score and subscale scores for each type of
maltreatment. Means, standard deviations, and ranges of the CTQ
scales in the present sample are given in Table 1. In order to avoid
using cut-offs and categorization, which, in the present sample,
would result in low absolute numbers of individuals reporting a
history of severe maltreatment, the total score was used as a
continuous measure of individual history of maltreatment.
On the other hand, exposure to childhood adversity was determined
according to an ‘enriched’ family adversity index as proposed by Rutter
and Quinton (1977). Information was derived from a standardized
parent interview conducted by trained interviewers at each assessment
during childhood (age 3 months; 2; 4.5; 8 and 11 years). The index
measures the presence of 11 adverse family factors, covering char-
acteristics of the parents (e.g., psychiatric disorder, low educational
level), the partnership (e.g., marital discord, early parenthood), and
the family environment (e. g., poor social integration, overcrowding)
during a period of 1 year prior to the assessment (Laucht et al., 1997,
2012). A total family adversity score was calculated by counting the
number of factors present in the period until 11 years of age. The
correlations between the family adversity score and CTQ measures are
shown in Table 1.
2.3. Trier Social Stress Test (TSST)
Participants arrived at the laboratory at 13:00. First, all subjects
were fully informed about the study procedures, including the
requirement to abstain from nicotine and caloric intake throughout
the experiment. Urine was screened for cannabinoids, opioids,
cocaine, methamphetamine, benzodiazepines, and amphetamines
using standard qualitative immunological methods (MAHSAN Diag-
nostika, Reinbek, Germany). A venous catheter was inserted for
blood sampling at 13:30. All subjects underwent a urine drug
screening. At 14:40, participants were introduced to the stress test
procedure, and this time was deﬁned as the onset of stress
exposure. They were then given 10 min to prepare an oral
presentation as for a job interview. After this, they performed
their presentation and a mental arithmetic task in front of three
researchers acting as an audience (Kirschbaum et al., 1993). Blood
samples were obtained before the introduction to the TSST and
immediately before and 10, 20, 35, 50, and 70 min after the
beginning of the speech. Cortisol analysis was performed as
described previously (Witt et al., 2011).
2.4. Genotyping
Genomic DNA was prepared from whole blood or saliva according to
standard procedures. Rs1360780 was genotyped using a pre-designed
TaqMan 5' nuclease SNP genotyping assay (Life Technologies, USA;
assay number: C_8852038_10). Accuracy was assessed by duplicating
15% of the original sample, yielding a reproducibility of 100%.
2.5. Statistical analysis
To examine genotype differences with regard to sex, smoking
status, female menstrual cycle phase, oral contraceptive use,
family adversity and childhood maltreatment, χ2 tests and ANOVAs
were conducted as appropriate. For the analysis of hormonal
responses, cortisol measures were transformed to the logarithmic
scale due to non-normality. First, a repeated measures ANCOVA
design was utilized to assess the effect of time, genotype and their
interactions on the hormonal response to the TSST. Cortisol varia-
tion was investigated until 70 min after the beginning of the speech
(7 assessments). Time after stress onset was applied as a within-
subject factor and genotype was included as a between-subject
factor. To examine intraindividual cortisol change, in a second set of
analyses, individual delta scores were formed, deﬁned as the
difference between the individual peak (in the period 35 min after
cessation of the TSST) and baseline hormone level (immediately
before the introduction to the TSST). Post-hoc univariate ANCOVAs
were performed to examine the impact of genotype on baseline
hormone level, delta variation and cortisol recovery (70 min after
the beginning of the speech). In a third step, the same analyses
were conducted, including family adversity and childhood maltreat-
ment, respectively, and their interaction with genotype as pre-
dictors of the individual cortisol response to stress. Both
measurements of childhood adversity were treated as continuous
variables. To control for the inﬂuence of gender, smoking status,
use of oral contraceptives and baseline cortisol level on the
hormonal stress response, these factors were included as covariates
in the analyses. Greenhouse–Geisser corrections were applied
where appropriate, and only adjusted results are reported.
3. Results
3.1. Sample characteristics
After excluding 45 individuals for reasons given in Table 2,
the ﬁnal sample included N=195 individuals. FKBP5
rs1360780 genotype frequencies were CC=94; CT=84 and
TT=17, which was in accordance with Hardy–Weinberg
equilibrium (χ2=.08, p=.773). Of the females, 70.5% were
using oral contraceptives (OC) and 47.6% were in the luteal
phase of their menstrual cycle. Information on menstrual
cycle phase was not available in 9.5%. Genotype groups did
not signiﬁcantly differ with respect to gender, use of oral
contraceptives, menstrual cycle phase (all χ2o3.10;
p4.307), family adversity [F(2, 192)=.40, p=.672] or
childhood maltreatment [F=.07(2, 192), p=.929]. However,
there was a trend towards a lower number of daily smokers
in the CT genotype group (χ2=4.97; p=.083, Table 2).
3.2. Effect of FKBP5 polymorphism
Signiﬁcant changes in plasma cortisol emerged due to stress
exposure, with an increase following the TSST procedure
and a decrease after stress cessation [main effect of time: F
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(6, 1134)=83.16, po.001]. In addition, a signiﬁcant time by
genotype interaction was observed [F(12,1134)=2.93,
p=.008; see Figure 1], indicating that carriers of the
rs1360780 T allele displayed a more pronounced cortisol
response to the TSST than homozygous carriers of the C
allele. Post-hoc analyses revealed that the pre-stress
plasma cortisol concentration and the individual cortisol
increase in response to the TSST (delta) were unaffected by
genotype [baseline: F(2,189)=1.20, p=.30; delta: F(2, 189)
=.39, p=.676]. However, signiﬁcant group differences
emerged regarding cortisol recovery after completion of
the stress test [F(2,188)=3.63, p=.028]. When cortisol was
measured 70 min after speech onset, carriers of the CC
genotype showed signiﬁcantly lower cortisol levels than CT
(p=.027) and TT (p=.042) carriers, while no difference in
cortisol recovery was observed among the latter groups (CT
vs. TT: p=.451).
3.3. Effect of gene–environment interaction
Based on these results and due to the small number of T
homozygotes, individuals carrying the CT or TT genotypes
were combined into one group in the subsequent analyses
examining gene–environment interaction effects. While
there was no signiﬁcant three-way interaction of genotype
by family adversity by time [F(6,1128)=.458, p=.713],
repeated measures ANCOVA revealed a signiﬁcant three-
way interaction of FKBP5 genotype by childhood maltreat-
ment by time to predict cortisol stress response [F(6,1128)
=2.629, p=.049; Figure 2]. Post-hoc analyses revealed that
the impact of exposure to childhood maltreatment on
cortisol recovery was signiﬁcantly moderated by FKBP5
genotype [interaction genotype by maltreatment F(1,187)
=4.65, p=.032]. However, neither pre-stress plasma corti-
sol concentration nor delta cortisol was affected by the
interaction between childhood maltreatment and genotype.
In homozygote carriers of the C allele, severity of childhood
maltreatment was signiﬁcantly associated with decreasing
overall cortisol levels [F(1,89)=5.23, p=.008] and faster
cortisol recovery when assessed 70 min after speech onset
[F(1, 88)=10.29, p=.002]. In contrast, childhood maltreat-
ment was unrelated to cortisol stress reactivity [F(1,96)
=.01, p=.947] and cortisol recovery [F(1,95)=.03, p=.856]
in carriers of the T allele.
4. Discussion
In accordance with previous research (Ising et al., 2008; Luijk
et al., 2010), the T allele of the FKBP5 rs1360780 polymorph-
ism was found to be associated with delayed cortisol recovery
Table 1 Means, standard deviations (SD), and ranges of the childhood adversity measures in the study sample (N=195).
CTQ scale Mean (SD) Range N (%) above the threshold for Correlation with
family adversity score
Low Moderate Severe
Total score 30.68 (7.56) 25–87 .272n
Emotional abuse 6.48 (2.83) 5–25 18 (9.2) 6 (3.1) 3 (1.5) .162n
Physical abuse 5.41 (1.60) 5–22 6 (3.1) 3 (1.5) 1 (.5) .153n
Sexual abuse 5.14 (.76) 5–12 6 (3.1) 2 (1.0) 0 (0) .052
Emotional neglect 7.95 (3.17) 5–24 39 (20.0) 6 (3.1) 2 (1.0) .292n
Physical neglect 5.70 (1.33) 5–12 10 (5.1) 7 (3.6) 0 (0) .291n
Family adversity score 3.65 (2.43) 0–10
CTQ=Childhood Trauma Questionnaire
np o.05
Table 2 Sample characteristics by FKBP5 rs1360780 genotype.
FKBP5 rs1360780 genotype CC CT TT
TSST sample (N=240) 116 102 22
Excluded for (N)
Positive drug screening 8 4 2
DSM IV substance use disorder 5 2 1
Missing or implausible cortisol data 9 12 2
Evaluated (N=195) 94 84 17
Males N (%) 45 (47.9) 38 (45.2) 7 (41.2)
Daily smokers N (%) 31 (33.0) 16 (19.0) 6 (35.3)
Females with oral contraceptive use N (%) 31 (63.3) 35 (76.1) 8 (80.0)
Family adversity score M (SD) 1.86 (1.95) 1.61 (1.84) 1.71 (1.93)
CTQ total score M (SD) 30.53 (8.13) 30.71 (7.15) 31.29 (6.65)
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after exposure to acute psychosocial stress. Enhanced induc-
tion of FKBP5 mRNA in association with this polymorphism was
suggested to interfere with the GR-mediated negative feed-
back (Binder et al., 2004), thereby predisposing T-allele
carriers to HPA dysregulation typical for stress-related dis-
orders. In particular, when exposed to childhood adversity, an
increased risk of psychiatric disease has been documented
among risk allele carriers. However, to the best of our
knowledge, this is the ﬁrst study to demonstrate FKBP5-
dependent long-term effects of childhood maltreatment on
the hormonal response to stress.
In contrast to a previous investigation reporting an additive
effect of FKBP5 rs1360780 and environmental adversity in
predicting cortisol reactivity in infants (Luijk et al., 2010), a
signiﬁcant interaction of genotype with childhood maltreat-
ment emerged in the current study. Our results indicated
faster cortisol recovery after acute stress in young adults with
the CC genotype who had been exposed to maltreatment
during childhood, whereas no signiﬁcant association of child-
hood maltreatment with the cortisol stress response was
observed among T-allele carriers. Several reasons may account
for the discrepant ﬁndings, including age-dependent effects
and methodological differences in stress induction and cortisol
sampling. Moreover, insecure-resistant attachment was con-
sidered as an indirect marker of environmental adversity
during infancy by Luijk et al. (2010), whereas the present
study compared two different measures of childhood adver-
sity. Gene–environment interaction related to cortisol stress
response was demonstrated for exposure to childhood mal-
treatment as assessed by retrospective self-report, but not for
a prospectively ascertained objective measure of adversity.
This ﬁnding is in line with previous evidence suggesting
that the CTQ may identify individuals who are genetically
susceptible to stress-related disorders due to increased
consolidation of memories of emotionally arousing experi-
ences (Polanczyk et al., 2009). On the one hand, the family
adversity index used here has the advantage of being largely
independent of memory effects of the participants, as it
was assessed by trained interviewers in repeatedly con-
ducted parent interviews. Therefore, it might include
information that was not recalled by the young adults. On
the other hand, we cannot rule out that the absence of an
rs1360780 by family adversity interaction is due to the fact
that this measure covers qualitatively different stressors
than the CTQ. In particular, the family adversity index did
not address childhood maltreatment per se but rather
pertained to a more broader spectrum of adverse conditions
such as marital discord or parental psychiatric illness (see
also Supplementary Table 1). Thus, the moderating effect of
FKBP5 might be speciﬁc to the type of maltreatment
experienced (emotional maltreatment, neglect, physical
abuse or sexual abuse as assessed by the CTQ). However,
FKBP5 rs1360780 genotype
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Figure 1 Cortisol responses to the TSST depending on FKBP5
rs1360780 genotype. Error bars represent SE (*signiﬁcant group
difference, po.05).
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Figure 2 Cortisol responses to the TSST depending on the
interaction between FKBP5 rs1360780 genotype and exposure
to childhood maltreatment (CTQ total). Median split of the CTQ
was used to visualize the gene by environment interaction
(Mdn=28). While a higher level of maltreatment was associated
with signiﬁcantly reduced cortisol levels in (a) FKBP5 rs1360780
CC carriers, the cortisol stress response was unaffected in
carriers of the (b) FKBP5 rs1360780 T allele. Error bars
represent SE (*signiﬁcant group difference, po.05).
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epidemiological surveys documenting the detrimental
impact of adverse experiences during on mental health
have suggested that the risk of psychiatric disorders
increased with the number of multiple adversities indicative
of maladaptive family functioning which were not limited to
physical and sexual abuse or neglect (Green et al., 2010;
Kessler et al., 2012).
Recently, Klengel et al. (2013) identiﬁed a molecular
mechanism which they suggested as explaining a genotype-
moderated effect of exposure to childhood adversity on
stress hormone system regulation. The authors reported
signiﬁcant variation of DNA methylation of the FKBP5 locus
according to rs1360780 genotype. While childhood maltreat-
ment proved to be associated with FKBP5 demethylation in
carriers of the T allele, no such effect was observed among
C homozygotes. Such epigenetic-induced changes result in
higher FKBP5 responsiveness, probably increasing the risk of
dysregulation of the stress hormone system, such as in
stress-related disorders. A delayed cortisol recovery may,
therefore, be regarded as a prominent risk factor, predis-
posing FKBP5 risk allele carriers to stress-related disease.
Surprisingly, the present study revealed no additional
increase in cortisol levels among carriers of the FKBP5 T
allele due to exposure to childhood maltreatment. Instead,
homozygous carriers of the C allele showed signiﬁcant
attenuation of the cortisol response to stress. Concerning
the implications of childhood maltreatment for the hormo-
nal stress system, disparate ﬁndings have been reported in
the literature, including both hyper- and hyporeactivity.
Prospective longitudinal research has indicated that adverse
experiences in childhood initially lead to higher cortisol
levels, which may become suppressed over time (Trickett
et al., 2010). It was suggested that the attenuation of
stress-regulatory responses may develop as an adaptive
process to avoid chronic activation and to protect indivi-
duals experiencing childhood adversity against the deleter-
ious effects of long-term exaggerated glucocorticoid
exposure (Susman, 2006). Saxbe et al. (2012), for instance,
reported that decreased cortisol reactivity during a conﬂict
task was associated with lower psychological and behavioral
problems among youths who grew up in aggressive family
environments, whereas a more exaggerated cortisol reac-
tivity appeared to be rather maladaptive in the context of
an aggressive family environment. Thus, a blunted cortisol
response to environmental challenges, as observed in
rs1360780 CC carriers, may be viewed as indicative of an
enhanced biological resilience in healthy individuals with a
history of childhood adversity (Saxbe et al., 2012; Elzinga
et al., 2008). Corresponding evidence was provided earlier
on by animal studies in the framework of the stress-
inoculation model, which assumes that stress exposure in
early life may increase resilience to stressful events later in
life (Parker and Maestripieri, 2011). Mechanisms responsible
for this counterregulatory adaptation were assumed to
include increased hippocampal GR expression (Kaffman
and Meaney, 2007) or increased negative feedback sensitiv-
ity of the HPA system (Heim et al., 2000).
On the other hand, as cortisol hyposecretion has been
linked to psychopathology, such as externalizing problems
(Fairchild et al., 2008; Popma et al., 2006; van Goozen
et al., 1998), posttraumatic stress disorder and other stress-
related disorders (Heim et al., 2000), it could also
constitute a risk factor for the development of these
disorders. Whether childhood adversity leads to risk or
resilience is likely to be attributable to the type (e.g.
family adversity vs. maltreatment) or the timing of expo-
sure but also to moderating factors such as genotype.
Emerging evidence has outlined the important role of FKBP5
in the vulnerability to stress-related psychiatric disorders
(Binder et al., 2008; Kang et al., 2012; Zimmermann et al.,
2011). In accordance with this, the present results could be
interpreted as suggesting that, instead of stress inoculation,
T-allele carriers exposed to childhood maltreatment may
exhibit a sensitization of emotion processing systems. An
increased hormonal stress response may thus be accompa-
nied by a heightened vigilance towards threatening infor-
mation as suggested by Fani et al. (2013). These authors
reported increased activation of the hippocampus and
attentional bias to angry faces among traumatized carriers
of the rs1360780 T allele. Correspondingly, the FKBP5
genotype has been implicated in amygdala activation to
threat-related stimuli in the context of childhood emotional
neglect (White et al., 2012). While in TT carriers amygdala
activity was shown to increase with the level of childhood
neglect, no such effect was observed in CC carriers.
When evaluating the present ﬁndings, several issues have
to be considered. First, the sample size of this study was
relatively small for a genetic association study. Hence, the
results have to be considered as exploratory in nature and
should be replicated in independent samples. Second, since
repeated exposure to the stress paradigm applied here
could have resulted in a more valid estimate of the cortisol
response pattern (Federenko et al., 2004), the contribution
of FKBP5 genotype to individual variation in cortisol reac-
tivity was likely underestimated in the present study due to
the use of a single TSST assessment. Third, the present
investigation comprised a community sample of young
adults characterized by low levels of exposure to severe
childhood maltreatment, as assessed by the CTQ. This
restriction clearly reduces the ability to generalize the
present ﬁndings to other samples with higher exposure to
childhood adversity, in particular physical or sexual abuse.
Most previous studies relied on categorical measures using
cut-offs to deﬁne severe cases of maltreatment. In contrast,
the present investigation conducted in an epidemiological
cohort sample used a continuous measure of individual
history of childhood maltreatment, thus also including a
greater number of mild cases. Therefore, the ﬁndings
reported here may be interpreted as extending the current
evidence of the FKBP5 by childhood adversity interaction to
a less narrow deﬁnition of maltreatment. Fourth, due to the
low number of individuals exposed to severe maltreatment,
the statistical power to address the research questions is
limited. Given the ﬁnding by Klengel et al. (2013), one
would clearly expect the abused homozygous T allele
carriers to demonstrate higher and prolonged cortisol
responses than the abused C allele carriers. However, in
the present study, it remained unclear whether such an
effect emerged, as CT and TT carriers had to be combined
due to the small sample size.
In addition, the sample of this study was initially enriched
with children who grew up in an environment characterized
by several indicators of maladaptive family function which
have been shown to be more frequently associated with
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maltreatment than by random chance. Studies examining
the effects of childhood adversity on HPA axis function in
the long run have been confronted with the problem that,
among participants exposed to high levels of adversity, the
rate of individuals suffering from organic or psychiatric
diseases (including intoxication with drugs of abuse or
psychoactive medication) was enhanced, thereby increasing
the risk of confounding the results. To demonstrate this
problem in the present sample, signiﬁcantly higher CTQ
scores were obtained among participants excluded from the
investigation for reasons given in Table 2 (CTQ total score:
M=34.24, SD=13.22) as compared to the evaluated TSST
sample (F (1, 238)=5.90, p =.016). Another shortcoming of
the present study is that the participants completed the
CTQ 4 years after their participation in the TSST, while
psychopathology was not assessed in parallel. As Polanczyk
et al. (2009) clearly noted, the CTQ taps depression-
relevant emotional memories, therefore, we cannot rule
out that the incidence of psychiatric disorders at the time of
CTQ assessment may have affected the results.
To summarize, our results indicated that a genetic variant
of FKBP5 that has been repeatedly associated with an
increased risk of depression and other stress-related dis-
orders (Binder, 2009) moderated the long-term impact of
childhood maltreatment on the hormonal stress regulation
system. As GR-mediated feedback mechanisms have been
suggested to play a major role in the pathophysiology of
psychiatric disorders (Holsboer, 2000) and to affect anti-
depressant treatment (Binder, 2009), future clinical studies
should investigate the signiﬁcance of gene-environment
interaction in predicting individual treatment responses.
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